|
1
|
de Oliveira MB, Koshkin V, Liu G and
Krylov SN: Analytical challenges in development of chemoresistance
predictors for precision oncology. Anal Chem. 92:12101–12110. 2020.
View Article : Google Scholar
|
|
2
|
Akman M, Belisario DC, Salaroglio IC,
Kopecka J, Donadelli M, De Smaele E and Riganti C: Hypoxia,
endoplasmic reticulum stress and chemoresistance: Dangerous
liaisons. J Exp Clin Cancer Res. 40:282021. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
McAleese CE, Choudhury C, Butcher NJ and
Minchin RF: Hypoxia-mediated drug resistance in breast cancers.
Cancer Lett. 502:189–199. 2021. View Article : Google Scholar
|
|
4
|
Dzhalilova DS and Makarova OV:
HIF-dependent mechanisms of relationship between hypoxia tolerance
and tumor development. Biochemistry (Mosc). 86:1163–1180. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang M, Liu Q, Li L, Ning J, Tu J, Lei X,
Mo Z and Tang S: Cytoplasmic M-CSF facilitates apoptosis resistance
by inhibiting the HIF-1α/BNIP3/Bax signalling pathway in MCF-7
cells. Oncol Rep. 41:1807–1816. 2019.
|
|
6
|
Xu D, Li DW, Xie J and Chen XW: Effect and
mechanism of survivin on hypoxia-induced multidrug resistance of
human laryngeal carcinoma cells. Biomed Res Int.
2019:56968012019.
|
|
7
|
Yun CW, Lee JH and Lee SH: Hypoxia-induced
PGC-1α regulates mitochondrial function and tumorigenesis of
colorectal cancer cells. Anticancer Res. 39:4865–4876. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang Y, Qi Z, Zhou M, Yang W, Hu R, Li G,
Ma X and Zhang Z: Stanniocalcin-1 promotes cell proliferation,
chemoresistance and metastasis in hypoxic gastric cancer cells via
Bcl-2. Oncol Rep. 41:1998–2008. 2019.
|
|
9
|
Zeng J, Huang T, Xue M, Chen J, Feng L, Du
R and Feng Y: Current knowledge and development of hederagenin as a
promising medicinal agent: A comprehensive review. RSC Adv.
8:24188–24202. 2018. View Article : Google Scholar
|
|
10
|
Wang J, Wu D, Zhang J, Liu H, Wu J and
Dong W: α-Hederin induces apoptosis of esophageal squamous cell
carcinoma via an oxidative and mitochondrial-dependent pathway. Dig
Dis Sci. 64:3528–3538. 2019. View Article : Google Scholar
|
|
11
|
Liu Y, Lei H, Ma J, Deng H, He P and Dong
W: α-Hederin increases the apoptosis of cisplatin-resistant gastric
cancer cells by activating mitochondrial pathway in vivo and vitro.
Onco Targets Ther. 12:8737–8750. 2019. View Article : Google Scholar
|
|
12
|
Sun J, Feng Y, Wang Y, Ji Q, Cai G, Shi L,
Wang Y, Huang Y, Zhang J and Li Q: α-hederin induces autophagic
cell death in colorectal cancer cells through reactive oxygen
species dependent AMPK/mTOR signaling pathway activation. Int J
Oncol. 54:1601–1612. 2019.PubMed/NCBI
|
|
13
|
Fang C, Liu Y, Chen L, Luo Y, Cui Y, Zhang
N, Liu P, Zhou M and Xie Y: α-Hederin inhibits the growth of lung
cancer A549 cells in vitro and in vivo by decreasing SIRT6
dependent glycolysis. Pharm Biol. 59:11–20. 2021. View Article : Google Scholar
|
|
14
|
Wang J, Deng H, Zhang J, Wu D, Li J, Ma J
and Dong W: α-Hederin induces the apoptosis of gastric cancer cells
accompanied by glutathione decrement and reactive oxygen species
generation via activating mitochondrial dependent pathway.
Phytother Res. 34:601–611. 2020. View Article : Google Scholar
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
16
|
Kim D, Langmead B and Salzberg SL: HISAT:
A fast spliced aligner with low memory requirements. Nat Methods.
12:357–360. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Anders S, Pyl PT and Huber W: HTSeq-a
Python framework to work with high-throughput sequencing data.
Bioinformatics. 31:166–169. 2015. View Article : Google Scholar
|
|
18
|
Roberts A, Pimentel H, Trapnell C and
Pachter L: Identification of novel transcripts in annotated genomes
using RNA-Seq. Bioinformatics. 27:2325–2329. 2011. View Article : Google Scholar
|
|
19
|
Zhan Y, Qiu Y, Wang H, Wang Z, Xu J, Fan
G, Xu J, Li W, Cao Y, Le VM, et al: Bufalin reverses multidrug
resistance by regulating stemness through the CD133/nuclear
factor-κB/MDR1 pathway in colorectal cancer. Cancer Sci.
111:1619–1630. 2020. View Article : Google Scholar
|
|
20
|
Zhao X, Liu L, Li R, Wei X, Luan W, Liu P
and Zhao J: Hypoxia-inducible factor 1-α (HIF-1α) induces apoptosis
of human uterosacral ligament fibroblasts through the death
receptor and mitochondrial pathways. Med Sci Monit. 24:8722–8733.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Valladares KJP, Balbinot KM, de Moraes AT,
Kataoka MSDS, Ramos AMPC, Ramos RTJ, da Silva ALDC, Mesquita RA,
Normando D, Júnior SM and de Jesus Viana Pinheiro J: HIF-1α is
associated with resistance to hypoxia-induced apoptosis in
ameloblastoma. Int J Dent. 2021:30603752021. View Article : Google Scholar
|
|
22
|
Ding Q, Kong X, Zhong W and Liu W: Fecal
biomarkers: Non-invasive diagnosis of colorectal cancer. Front
Oncol. 12:9719302022. View Article : Google Scholar
|
|
23
|
Zhang L, Lu Z and Zhao X: Targeting Bcl-2
for cancer therapy. Biochim Biophys Acta Rev Cancer.
1876:1885692021. View Article : Google Scholar
|
|
24
|
Belisario DC, Kopecka J, Pasino M, Akman
M, De Smaele E, Donadelli M and Riganti C: Hypoxia dictates
metabolic rewiring of tumors: Implications for Chemoresistance.
Cells. 9:25982020. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu J, Gao L, Zhan N, Xu P, Yang J, Yuan
F, Xu Y, Cai Q, Geng R and Chen Q: Hypoxia induced ferritin light
chain (FTL) promoted epithelia mesenchymal transition and
chemoresistance of glioma. J Exp Clin Cancer Res. 39:1372020.
View Article : Google Scholar :
|
|
26
|
Cao Y, Jiang Z, Zeng Z, Liu Y, Gu Y, Ji Y,
Zhao Y and Li Y: Bcl-2 silencing attenuates hypoxia-induced
apoptosis resistance in pulmonary microvascular endothelial cells.
Apoptosis. 21:69–84. 2016. View Article : Google Scholar
|
|
27
|
Letai A, Sorcinelli MD, Beard C and
Korsmeyer SJ: Antiapoptotic BCL-2 is required for maintenance of a
model leukemia. Cancer Cell. 6:241–249. 2004. View Article : Google Scholar
|
|
28
|
Goff DJ, Recart AC, Sadarangani A, Chun
HJ, Barrett CL, Krajewska M, Leu H, Low-Marchelli J, Ma W, Shih AY,
et al: A Pan-BCL2 inhibitor renders bone-marrow-resident human
leukemia stem cells sensitive to tyrosine kinase inhibition. Cell
Stem Cell. 12:316–328. 2013. View Article : Google Scholar
|
|
29
|
Delbridge AR, Grabow S, Strasser A and
Vaux DL: Thirty years of BCL-2: Translating cell death discoveries
into novel cancer therapies. Nat Rev Cancer. 16:99–109. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lee J, Sohn EJ, Yoon SW, Kim CG, Lee S,
Kim JY, Baek N and Kim SH: Anti-metastatic effect of
dehydrocorydaline on H1299 non-small cell lung carcinoma cells via
inhibition of matrix metalloproteinases and B cell lymphoma 2.
Phytother Res. 31:441–448. 2017. View Article : Google Scholar
|
|
31
|
Davids MS and Letai A: ABT-199: Taking
dead aim at BCL-2. Cancer. Cell. 23:139–141. 2013.
|
|
32
|
Li JR, Ren J, Yang SC, Han JQ, Guo YJ and
Ji ES: Effect of xiaotan huayu liqiao traditional Chinese medicine
compound on myocardial fibrosis in rats with chronic intermittent
hypoxia and its mechanism. Zhongguo Ying Yong Sheng Li Xue Za Zhi.
36:414–418. 2020.In Chinese.
|
|
33
|
Peng W and Zhang S, Zhang Z, Xu P, Mao D,
Huang S, Chen B, Zhang C and Zhang S: Jianpi Jiedu decoction, a
traditional Chinese medicine formula, inhibits tumorigenesis,
metastasis, and angiogenesis through the mTOR/HIF-1α/VEGF pathway.
J Ethnopharmacol. 224:140–148. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li RL, He LY, Zhang Q, Liu J, Lu F, Duan
HX, Fan LH, Peng W, Huang YL and Wu CJ: HIF-1α is a potential
molecular target for herbal medicine to treat diseases. Drug Des
Devel Ther. 14:4915–4949. 2020. View Article : Google Scholar
|
|
35
|
Rooney S and Ryan MF: Efects of α-hederin
and thymoquinone, constituents of Nigella sativa, on human cancer
cell lines. Anticancer Res. 25:2199–2204. 2005.PubMed/NCBI
|
|
36
|
Lorent JH, Léonard C, Abouzi M, Akabi F,
Quetin-Leclercq J and Mingeot-Leclercq MP: α-Hederin induces
apoptosis, membrane permeabilization and morphologic changes in two
cancer cell lines through a cholesterol-dependent mechanism. Planta
Med. 82:1532–1539. 2016. View Article : Google Scholar
|
|
37
|
Fallahi M, Keyhanmanesh R, Khamaneh AM,
Saadatlou MA, Saadat S and Ebrahimi H: Efect of alpha-hederin, the
active constituent of Nigella sativa, on miRNA126, IL-13 mRNA
levels and infammation of lungs in ovalbuminsensitized male rats.
Avicenna J Phytomed. 6:77–85. 2016.
|
|
38
|
Keyhanmanesh R, Saadat S, Mohammadi M,
Shahbazfar AA and Fallahi M: The protective efect of α-hederin, the
active constituent of nigella sativa, on lung infammation and blood
cytokines in ovalbumin sensitized guinea pigs. Phytother Res.
29:1761–1767. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Li J, Wu DD, Zhang JX, Wang J, Ma JJ, Hu X
and Dong WG: Mitochondrial pathway mediated by reactive oxygen
species involvement in α-hederin-induced apoptosis in
hepatocellular carcinoma cells. World J Gastroenterol.
24:1901–1910. 2018. View Article : Google Scholar :
|
|
40
|
Cheng L, Xia TS, Wang YF, Zhou W, Liang
XQ, Xue JQ, Shi L, Wang Y, Ding Q and Wang M: The anticancer efect
and mechanism of α-hederin on breast cancer cells. Int J Oncol.
45:757–763. 2014. View Article : Google Scholar
|
